MPACT Study to Compare Effects of Targeted Drugs on Tumor Gene Variations

Clinical trial NCT01827384 · COMPLETED

Trial details

NCT number: NCT01827384
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Malignant Solid Neoplasm

Start date: 2014-01-07
Primary completion: 2021-06-19
Enrollment: 208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.